Cargando…
Effect of Treatment for CHC on Liver Disease Progression and Hepatocellular Carcinoma Development in African Americans
Background and Aims: African Americans (AA) historically have a low response rate to hepatitis C therapies, and there is limited information available for this patient population regarding the development and treatment of chronic hepatitis C (CHC). The aim of this study was to evaluate liver disease...
Autores principales: | Reddy, Naveen, Naylor, Paul, Hakim, Zaher, Asbahi, Redwan, Ravindran, Karthik, May, Elizabeth, Ehrinpreis, Murray, Mutchnick, Milton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663197/ https://www.ncbi.nlm.nih.gov/pubmed/26623262 http://dx.doi.org/10.14218/JCTH.2015.00013 |
Ejemplares similares
-
Overestimate of Fibrosis by FIBROSpect® II in African Americans Complicates the Management of their Chronic Hepatitis C
por: Tama, Maher, et al.
Publicado: (2016) -
Racial Disparity in HCV Demographics and Treatment Between Interferon Era (2002–2003) and Direct Acting Anti-viral Era (2019)
por: Naylor, Paul, et al.
Publicado: (2023) -
Demographics of a large cohort of urban chronic hepatitis C patients
por: Siddiqui, Firdous A., et al.
Publicado: (2008) -
Hepatic Sinusoidal Obstruction Syndrome in a Patient With Multiple Myeloma Treated With CyBorD
por: Tariq, Tooba, et al.
Publicado: (2019) -
CHC22 and CHC17 clathrins have distinct biochemical properties and display differential regulation and function
por: Dannhauser, Philip N., et al.
Publicado: (2017)